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Evaluation of Changes of Macular Thickness in Diabetic 
Retinopathy after Cataract Surgery
Soon Il Kwon, Duck Jin Hwang, Ji Young Seo, In Won Park
Department of Ophthalmology, Hallym University Sacred Heart Hospital, Anyang, Korea
Purpose: To assess the macular thickness changes after cataract surgery in diabetic patients using optical coher-
ence tomography (OCT).
Methods: We retrospectively reviewed the records of 104 diabetic patients who underwent cataract surgery. We ex-
amined the changes of macular thickness using OCT before cataract surgery and 1 week, 1-, 2- and 6-months af-
ter surgery. The central subfield mean thickness (CSMT) was used to evaluate macular edema which was de-
fined as an increase of CSMT (ΔCSMT) > 30% from the baseline. The association between prior laser treatment 
or severity of diabetic retinopathy and macular thickness were also analyzed.
Results: Macular edema occurred in 19 eyes (18%) from the diabetic group and 63% of macular edema developed 
at 1 month after surgery. Thirteen (68%) out of 19 eyes with macular edema showed the resolution of macular 
edema by 6 months after surgery without treatment. ΔCSMT of eyes without a history of laser treatment was stat-
istically greater compared to eyes with a history of laser treatment in at 1- and 2-months after surgery, but was not 
different than eyes who had laser treatment at 6-months after surgery. The severity of diabetic retinopathy was 
not significantly correlated to macular edema, but there was statistical difference when patients who had a history 
of prior laser treatment were excluded.
Conclusions: The incidence of macular edema after cataract surgery in diabetic patients was 18%. Its peak in-
cidence was at 1 month post surgery and it resolved spontaneously in 68% of patients by 6 months post surgery. 
Prior laser treatment might prevent postoperative macular edema until 2 months after cataract surgery in diabetic 
patients. However, macular edema did not affect the severity of diabetic retinopathy.
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Macular edema is a common cause of unfavorable visual 
outcome after cataract surgery. Clinically significant cystoid 
macular edema (CSME) has a reported incidence of 1% to 
2% after cataract surgery [1]. Diabetes has been associated 
with an increased incidence of postoperative macular edema. 
The incidence of macular edema on optical coherence to-
mography (OCT) was 22% in diabetic eyes undergoing cata-
ract surgery [2]. The macular edema after cataract surgery in 
diabetic patients could be caused by the cataract surgery or 
diabetes itself, but it might be hard to differentiate between 
these two causes.
OCT has been shown to be highly reproducible in measur-
ing macular thickness in normal individuals and diabetic pa-
tients [3,4]. For detecting macular edema, OCT is superior to 
contact lens biomicroscopy and as effective as fluorescein 
angiography (FAG) [5]. Since OCT can assess macular 
thickness quantitatively, it can detect subtle changes of mac-
ular thickness and is especially useful in mild cases.
In a previous report, diabetic eyes with CSME at the time 
of cataract surgery showed persistent CSME throughout the 
first postoperative year and showed no tendency to resolve 
spontaneously [6]. For diabetic eyes without CSME at the 
time of cataract surgery, macular edema after cataract sur-
gery resolved spontaneously in 50% of cases by 6 months 
and in 75% of cases by 1 year. However, a relatively small 
number of patients (n = 32) were enrolled in this study and it 
would be even smaller if the eyes with CSME at the time of 
surgery were excluded. Therefore, this is not enough evi-






Age (yr) 68.21 ± 9.09
SE (diopter)   1.25 ± 0.68
Preoperative BCVA (logMAR)   0.57 ± 0.47
Preoperative CSMT 164.42 ± 25.02
Diabetic retinopathy stage
No diabetic retinopathy         61 (58.65%)
Mild to moderate NPDR         27 (25.96%)
Severe NPDR or PDR         16 (15.38%)
Postoperative complications
Macular edema         19 (18.27%)
IOP elevation         5 (4.81%)
Vitreous hemorrhage         2 (1.92%)
Posterior capsular opacity         1 (0.96%)
Retinopathy progression         12 (11.54%)
BCVA = best corrected visual acuity; logMAR = logarithm of the 
minimal angle of resolution; CSMT = central subfield macular 
thickness; NPDR = non proliferative diabetic retinopathy; PDR 
= proliferative diabetic retinopathy; IOP = intraocular pressure.
cataract surgery. Moreover, the macular edema was assessed 
by FAG in this study and it is difficult to detect subtle 
changes of macular thickness using FAG.
In this study, we assessed the changes of macular thickness 
in diabetic patients after cataract surgery using OCT and also 
examined the influence of preoperative laser treatment and 
severity of diabetic retinopathy on macular thickness.
Materials and Methods
We reviewed the records of the patients with type 2 dia-
betes mellitus who underwent phacoemulsification with in-
traocular lens insertion between January 2008 and December 
2008. A total of 104 eyes from 104 subjects were enrolled. 
Patients were excluded from the study if they had any of the 
following conditions: prior or concomitant surgery to the eye 
scheduled for cataract extraction such as vitreous surgery or 
glaucoma surgery, intraoperative complications, a history of 
macular edema within 6 months before the preoperative ex-
am, a history of ocular and systemic conditions known to be 
associated with potentially irreversible significant vision 
loss, presence of any retinal or choroidal disease other than 
diabetes that could affect retinal thickness, and less than 6 
months of follow-up care. Meanwhile, we included patients 
who had undergone laser photocoagulation for macular ede-
ma or for proliferative diabetic retinopathy (PDR) more than 
6 months prior to surgery. Cataract surgery was performed by 
one single surgeon (IWP). A limbal incision or clear corneal 
incision was made, and continuous curvilinear capsulor-
rhexis was performed. For cataract surgery, phacoemulsifica-
tion equipment (Legacy; Alcon Laboratories Inc., Fort 
Worth, TX, USA) was used. The nucleus was divided and 
phacoemulsification and aspiration were performed after 
cortical aspiration, an acrylic foldable IOL (Sensar AR40e; 
AMO, Santa Ana, CA, USA) was inserted in the capsular 
bag. Preoperative and postoperative examinations including 
best-corrected visual acuity using standard Korean visual 
acuity chart (Han’s chart), which was translated into a loga-
rithm of the minimal angle of resolution (logMAR) scale for 
analysis purposes, slit-lamp examination, fundus photog-
raphy and intraocular lens implantation were checked at ev-
ery follow-up visit. All patients were followed at 1 week, 1-, 
2-, 3- and 6-months after surgery.
OCT was performed using commercially available equip-
ment (software 3.0; Carl Zeiss Meditec, Dublin, CA, USA). 
After pupil dilation, a macular thickness map was generated. 
This standard OCT protocol uses six radially oriented scan 
lines to produce a topographical map of the macula and the 
mean value of 128 thickness values obtained in the central 
subfield, which is circular area of diameter 1 mm centered 
around the center point (central subfield mean thickness), 
was measured [7]. Central subfield mean thickness (CSMT) 
was evaluated every follow-up and we manually calculated 
the difference in the thickness (absolute change in thickness; 
ΔCSMT) from the baseline. We used the ΔCSMT to analyze 
the course of the macular edema because of the wide range of 
normal macular thickness. Macular edema was defined as 
30% or more increase of CSMT from preoperative thickness 
determined by OCT [2]. In addition, the influence of prior la-
ser treatment and severity of diabetic retinopathy on macular 
thickness was also analyzed. Study participants were divided 
based on the presence or absence of a history of photo-
coagulation (panretinal photocoagulation, focal or grid laser) 
and divided into 5 groups based on the severity of diabetic 
retinopathy (no diabetic retinopathy, mild-, moderate-, se-
vere non-proliferative diabetic retinopathy [NPDR], and 
PDR). The absolute change in macular thickness and the 
change of visual acuity were calculated at every follow-up 
after surgery and analyzed among comparative groups.
Statistical analysis was performed by SPSS ver. 12.0 
(SPSS Inc., Chicago, IL, USA). Descriptive statistics, in-
cluding mean and standard deviation were calculated for 
each group. Group comparisons were performed using the 
student t-test. Fisher’s exact, two-tailed test was used for 
analysis of data on a nominal scale. A p-value less than 0.05 
was considered statistically significant.
Results
The 104 subjects in this series were made up of 36 men and 
68 women and their mean age was 68.21 ± 9.09 years. Mean 
preoperative best-corrected visual acuity in logMAR units 
was 0.57 ± 0.47 and mean preoperative CSMT was 164.42 ± 
25.02 µm. The number of patients without diabetic retinop-
athy were 61 (58.65%), with mild to moderate NPDR were 
27 (25.96%), with severe NPDR or PDR were 16 (15.36%). 
Postoperative complications occurred in 39 eyes (37.5%). Korean J Ophthalmol Vol.25, No.4, 2011
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Fig. 1. The total and newly developed number of patients with mac-
ula edema after cataract surgery.
Table 2. Characteristics of diabetic patients according to the history of laser treatment
Non-laser group Laser group p-value
Demographics
Eyes (n) 90 14
Sex (male:female) 31:59 5:9
Age (yr) 69.46 ± 8.41 60.21 ± 9.54 >0.05
*
SE (diopter) 1.25 ± 0.76  1.22 ± 0.52 >0.05
*
Preop BCVA  0.56 ± 0.47 0.66 ± 0.4 >0.05
*
Preop CSMT 163.16 ± 26.09 172.50 ± 23.43 >0.05
*
Incidence of macular edema        18 (20%)         1 (7.14%)      0.457
†
Diabetic retinopathy stage
No diabetic retinopathy         61 (67.78%)         0 (0%)
Mild to moderate NPDR         25 (27.78%)          2 (14.29%)
Severe NPDR or PDR         4 (4.44%)         12 (85.71%)
Retinopathy progression         11 (12.22%)         1 (7.14%)      0.699
†
BCVA = best corrected visual acuity; CSMT = central subfield macular thickness; NPDR = non proliferative diabetic retinopathy; 
PDR = proliferative diabetic retinopathy.
*Student t-test (p < 0.05).
†Fisher’s exact test (p < 0.05).
The most common complication was macular edema, which 
were occurred in 19 eyes (18.27%), followed by retinopathy 
progression (11.54%), elevation of intraocular pressure, vit-
reous hemorrhage, and posterior capsular opacity (Table 1).
Among the 19 eyes with macular edema, 12 eyes (63%) 
developed macular edema at 1 month after surgery, and 13 
eyes (68%) showed improvement of macular edema by 6 
months after surgery (Fig. 1). The remaining 6 eyes did not 
improve by 6 months and were followed for more than 1 year. 
Three eyes improved macular edema at 7, 8 and 12 months, 2 
eyes were treated with intravitreal triamcinolone acetonide at 
12 months, and 1 patient did not visit at 1 year after surgery. 
We explored the changes of macular thickness (ΔCSMT) 
using OCT. Because the laser photocoagulation could affect 
on macular thickness, the diabetic patients were divided into 
a laser group, which were patients who had a history of any 
photocoagulation, and a non-laser group, which were pa-
tients who had not had photocoagulation. Of the 104 diabetic 
patients, 14 had a history of photocoagulation (12 with pan-
retinal photocoagulation, 2 with focal laser). There were no 
statistical differences in baseline characteristics except the 
severity of diabetic retinopathy (Table 2). After cataract sur-
gery, it seemed that the incidence of macular edema and pro-
gression of retinopathy increased in the non-laser group com-
pared to the laser group, although it was not statistically 
significant. Compared to the laser group, ΔCSMT of the 
non-laser group was statistically significant at 1 and 2 
months after surgery. ΔCSMT was greatest at 1 month post 
surgery and gradually decreased in both groups thereafter 
(Fig. 2A). Similarly, ΔCSMT of the eye with macular edema 
(19 eyes) was greatest at 1 month after surgery and gradually 
decreased by 6 months, but was still significantly increased 
compared to the eyes without macular edema (Fig. 2B).
The changes of visual acuity (ΔlogMAR), which was not 
statistically significant between laser and non-laser groups, 
constantly improved in both groups (Fig. 3A). The visual 
acuity of the eyes without macular edema constantly im-
proved for 6 months after surgery. However, the visual acuity 
of the eyes with macular edema showed little improvement 
until 1 month after surgery and only improved after 2 months 
post surgery (Fig. 3B). Fifteen (79%) out of 19 patients with 
macular edema improved more than 0.1 logMAR, and 10 pa-
tients (53%) achieved logMAR of 0.1 or less (≥20 / 20) at 6 
months after surgery.
Severity of diabetic retinopathy was not significantly cor-
related to macular edema (p = 0.116). Since the laser treat-
ment could affect macular thickness and confuse the inter-
pretation of the results, we re-evaluated the correlation be-
tween severity of diabetic retinopathy and changes of mac-
ular thickness after patients who had prior laser treatment 
were excluded. We found that there was statistical difference 
in macular thickness through severity of diabetic retinopathy 
after exclusion of these patients (p = 0.017). SI Kwon, et al. Diabetic Macula Edema after Cataract Surgery
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A B
Fig. 2. The changes of central subfield macular thickness in eyes with and without prior laser treatment (A) and in eyes with and without mac-
ular edema (B) after cataract surgery. POD = postoperative day; ME = macular edema. 
*Student t-test (p < 0.05).
A B
Fig. 3. The changes of best corrected visual acuity in eyes with and without prior laser treatment (A) and in eyes with and without macular ede-
ma (B) after cataract surgery. logMAR = logarithm of the minimal angle of resolution; ME = macular edema. 
*Student t-test (p < 0.05).
Discussion
Macular edema after cataract surgery in diabetic patients 
could be caused by the cataract surgery (Irvine-Gass syn-
drome) or diabetes itself. Most of the macular edema after 
cataract surgery resolves spontaneously by 6 months, but dia-
betic macular edema tends to persist [8,9]. Therefore, it is 
recommended that laser therapy for macular edema be de-
ferred until 6 months after surgery to permit resolution of the 
Irvine-Gass element [9]. Dowler et al. [6] reported that 
CSME arising after surgery commonly resolved, particularly 
if retinopathy was mild. CSME occurred in half of the eyes in 
which CSME was absent at the time of surgery, with a peak 
incidence at 6 weeks. It resolved spontaneously by 6 months 
in half of the eyes affected and by 1 year in three quarters of 
the affected eyes. In our study, macular edema occurred in 19 
eyes (18%) and improved spontaneously by 6 months in 68% 
of eyes. Its peak incidence was at 1 month post surgery, 
which is similar compared to previous reports. However, the 
incidence of macular edema appears to be rather low com-
pared to previous studies, which reported incidence rates of 
29% to 56% and the proportion of improvement is slightly 
higher [6,10,11]. One explanation for this result might be that 
patients with previous laser treatment such as panretinal pho-
tocoagulation or laser treatment for macular edema were not 
excluded in our study. Early Treatment Diabetic Retinopathy 
Study (ETDRS) [12] reported that prior photocoagulation 
might be the reason for relatively good visual results and 
photocoagulation in patients with severe NPDR or CSME 
should be considered before lens surgery. They also recom-
mended that photocoagulation be considered before lens sur-
gery in patients with severe NPDR or CSME when possible 
[13].
The eyes without a history of laser therapy showed a stat-
istically significant increase in CSMT at 1 and 2 months after 
surgery compared to eyes with previous laser therapy. 
However, there was no statistical difference between the two 
groups at 6 months post surgery. From these results we could 
assume that prior laser treatment could lower the risk for ear-
ly postoperative macular edema until 2 months after surgery, 
but there would be little influence of the previous laser ther-
apy on macular thickness 6 months post surgery. ETDRS 
[10] reported that they did not observe an increased rate of 
macular edema after lens surgery. It is possible that the pho-
tocoagulation performed before surgery may have had a pro-
tective effect on the development of postoperative macular 
edema [14]. However, they assessed the rates of macular ede-
ma at 4-months after surgery. Thus, an accelerated rate of Korean J Ophthalmol Vol.25, No.4, 2011
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macular edema development immediately after surgery can-
not be ruled out. We presumed that early postoperative mac-
ular edema is due mostly to the Irvine-Gass component.
On the contrary, the improvement of visual acuity was not 
related to the history of laser treatment and the visual acuity 
improved even in eyes with macular edema at 6 months after 
surgery. There was no significant difference in visual acuity 
between the eyes with and without macular edema after 2 
months post surgery, although macular edema still remained 
as seen in the OCT. This result suggests that macular edema 
could be managed conservatively in diabetic patients.
In conclusion, this study demonstrated that 18% of dia-
betic patients developed increases in CSMT > 30% after cat-
aract surgery. Its peak incidence was at 1 month post surgery 
and it resolved spontaneously in 68% of patients by 6 months 
post surgery. This suggests that macular edema after cataract 
surgery in diabetic patients could be managed conservatively 
because it is likely to improve without treatment by 6 months 
post surgery, although prior laser treatment could lower the 
risk of early postoperative macular edema.
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